Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Arrivent Biopharma, Inc.

Clinical trials sponsored by Arrivent Biopharma, Inc., explained in plain language.

Trials to join now! 2 Not yet finished but already full! 1

New hope for tough-to-treat lung cancers as experimental drug enters human trials

Disease control Ongoing

This early-stage study is testing an experimental drug called furmonertinib for people with advanced lung cancer that has specific genetic mutations. The trial aims to find the safest and most effective dose while checking if the drug can shrink tumors. It involves 160 patients w…

Phase: PHASE1 • Sponsor: ArriVent BioPharma, Inc. • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC